| AGVGX | RWIBX | AGVGX / RWIBX | |
| Total Expense Ratio | 0.56 | 1.51 | 37% |
| Annual Report Gross Expense Ratio | 0.56 | 1.51 | 37% |
| Fund Existence | 7 years | 24 years | - |
| Gain YTD | 10.547 | 13.017 | 81% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 21.5B | 160B | 13% |
| Annual Yield % from dividends | 1.00 | 0.74 | 135% |
| Returns for 1 year | 24.55 | 17.83 | 138% |
| Returns for 3 years | 61.16 | 46.73 | 131% |
| Returns for 5 years | 56.94 | 27.84 | 205% |
| Returns for 10 years | N/A | 98.11 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BIPSX | 44.07 | N/A | N/A |
| ProFunds Biotechnology UltraSector Svc | |||
| TSVRX | 22.11 | N/A | N/A |
| PGIM Quant Solutions Small-Cap Val R | |||
| ACAYX | 66.15 | N/A | N/A |
| Alger Capital Appreciation Instl Y | |||
| FIJCX | 89.83 | N/A | N/A |
| Fidelity Advisor Consumer Staples Z | |||
| DFIEX | 22.01 | -0.42 | -1.87% |
| DFA International Core Equity 2 I | |||